Oral nanotherapeutics: Effect of redox nanoparticle on microflora in mice with dextran sodium sulfate-induced colitis

Journal of Gastroenterology

Volumn 49, Issue 5, 2014, Pages 806-813

  Vong, Long Binh ^a   Yoshitomi, Toru ^a   Morikawa, Kazuya ^a   Saito, Shinji ^a   Matsui, Hirofumi ^a   Nagasaki, Yukio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Colonic microflora; Inflammation; Reactive oxygen species; Redox nanoparticle; Ulcerative colitis

Indexed keywords

COPOLYMER; DEXTRAN SULFATE; DRINKING WATER; NANOPARTICLE; NITROXIDE; REDOX NANOPARTICLE; UNCLASSIFIED DRUG; REACTIVE OXYGEN METABOLITE;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DRUG SYNTHESIS; ESCHERICHIA COLI; FECES MICROFLORA; MICROBIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; ANIMAL; COLON; DISEASE MODEL; FECES; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; TOXICITY; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ANIMALS; COLITIS, ULCERATIVE; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FECES; MALE; MICE; MICE, INBRED ICR; NANOPARTICLES; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 84901408959     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-013-0836-8     Document Type: Article

References (38)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-29. (Pubitemid 34851835)
2. Edward VL. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-17.
3. Simmonds NJ, Rampton DS. Inflammatory bowel disease: a radical view. Gut. 1993;34:865-8. (Pubitemid 23203102)
4. Babbs CF. Oxygen radicals in ulcerative colitis. Free Radic Biol Med. 1992;13:169-81.
5. Gionchetti P, Rizzello F, Lammers KM, Morselli C, Sollazzi L, Davies S, et al. Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol. 2006;12:3306-13. (Pubitemid 43933773)
6. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nat Rev. 2011;44:307-17.
7. Sartor RB. The influence of normal microbial flora on the development of chronic inflammation. Res Immunol. 1997;148:567-76. (Pubitemid 28179021)
8. Strauch UG, Obermeier F, Grunwald N, Gürster S, Dunger N, Schultz M, et al. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut. 2005;54:1546-52. (Pubitemid 41531769)
9. Gibson GR, Roberfroid M. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125:1401-12.
10. Sasaki M, Klapproth J. The role of bacteria in the pathogenesis of ulcerative colitis. J Signal Transduct. 2012; doi: 10.1155/2012/704953.
11. Araki Y, Andoh A, Tsujikawa T, Fujiyama Y, Bamba T. Alterations in intestinal microflora, faecal bile acids and short chain fatty acids in dextran sulphate sodium-induced experimental acute colitis in rats. Eur J Gastroenterol Hepatol. 2011;13:107-12.
12. Vong LB, Tomita T, Yoshitomi T, Matsui H, Nagasaki Y. An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice. Gastroenterology. 2012;143:1027-36.e3.
13. Yoshitomi T, Miyamoto D, Nagasaki Y. Design of core-shell-type nanoparticles carrying stable radicals in the core. Biomacromolecules. 2009;10:596-601.
14. Yoshitomi T, Nagasaki Y. Nitroxyl radical-containing nanoparticles for novel nanomedicine against oxidative stress injury. Nanomedicine. 2011;6:509-18.
15. Solomon L, Mansor S, Mallon P, Donnelly E, Hoper M, Loughrey M, et al. The dextran sulphate sodium (DSS) model of colitis: an overview. Comp Clin Pathol. 2010;19:235-9.
16. Van der Waaij LA, Harmsen HJ, Madjipour M, Kroese FG, Zwiers M, van Dullemen HM, et al. Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm Bowel Dis. 2005;10:865-71. (Pubitemid 41428844)
17. Xia Y, Chen HQ, Zhang M, Jiang YQ, Hang XM, Qin HL. Effect of Lactobacillus plantarum LP-Only on gut flora and colitis in interleukin-10 knockout mice. J Gastroenterol Hepatol. 2011;26:405-11.
18. Vereecke L, Sze M, Mc Guire C, Rogiers B, Chu Y, Schmidt-Supprian M, et al. Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis. J Exp Med. 2010;207:1513-23.
19. Friend DR, Sellin J. Drug delivery in advancing the treatment of inflammatory bowel disease. Adv Drug Deliv Rev. 2005;57:215-6.
20. Hanauer SB. Medical therapy for ulcerative colitis 2004. Gastroenterology. 2004;126:1582-92. (Pubitemid 38649875)
21. Swidsinski A, Loening-Baucke V, Bengmark S, Lochs H, Dörffel Y. Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis. Inflamm Bowel Dis. 2007;1:51-6. (Pubitemid 46080009)
22. West B, Lendrum R, Hill MJ, Walker G. Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease. Gut. 1974;15:960-5.
23. Singh K, Chaturvedi R, Barry DP, Coburn LA, Asim M, Lewis ND, et al. The apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis. J Biol Chem. 2011;286:3839-50.
24. Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev. 2003;55:403-19. (Pubitemid 36293792)
25. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut. 2003;52:988-97. (Pubitemid 36765291)
26. Kotlowski R, Bernstein CN, Sepehri S, Krause DO. High prevalence of Escherichia coli belonging to the B2 + D phylogenetic group in inflammatory bowel disease. Gut. 2007;56:669-75. (Pubitemid 46662933)
27. Lu J, Wang A, Ansari S, Hershberg RM, McKay DM. Colonic bacterial superantigens evoke an inflammatory response and exaggerate disease in mice recovering from colitis. Gastroenterology. 2003;125:1785-95. (Pubitemid 37500443)
28. Vesterlund S, Karp M, Salminen S, Ouwehand AC. Staphylococcus aureus adheres to human intestinal mucus but can be displaced by certain lactic acid bacteria. Microbiology. 2006;152:1819-26.
29. Takaishi H, Matsuki T, Nakazawa A, Takada T, Kado S, Asahara T, et al. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int J Med Microbiol. 2008;298:463-72. (Pubitemid 351734793)
30. Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology. 2011;140:1729-37.
31. Hans W, Schölmerich J, Gross V, Falk W. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol. 2000;12:267-73. (Pubitemid 30168579)
32. Johansson ME, Gustafsson JK, Sjöberg KE, Petersson J, Holm L, Sjövall H, et al. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS ONE. 2010;5:e12238.
33. Zhou FX, Chen L, Liu XW, Ouyang CH, Wu XP, Wang XH, et al. Lactobacillus crispatus M206119 exacerbates murine DSS-colitis by interfering with inflammatory responses. World J Gastroenterol. 2012;18:2344-56.
34. Ganz T, Weiss J. Antimicrobial peptides of phagocytes and epithelia. Semin Hematol. 1997;34:343-54. (Pubitemid 27444137)
35. Pavlick KP, Laroux FS, Fuseler J, Wolf RE, Gray L, Hoffman J, et al. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med. 2002;33:311-22. (Pubitemid 34786271)
36. Roessner A, Kuester D, Malfertheiner P, Schneider-Stock R. Oxidative stress in ulcerative colitis-associated carcinogenesis. Pathol Res Pract. 2008;204:511-24.
37. Keshavarzian A, Fusunyan RD, Jacyno M, Winship D, Mac-Dermott RP, Sanderson IR. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am J Gastroenterol. 1999;94:04-12.
38. Brownlee IA, Knight J, Dettmar PW, Pearson JP. Action of reactive oxygen species on colonic mucus secretions. Free Radic Biol Med. 2007;43:800-8. (Pubitemid 47411490)